Sartorius Aktiengesellschaft (0NIQ.L)
EUR 192.8
(5.7%)
EUR 192.8
(5.7%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 3.39 Billion EUR | -18.66% |
| 2022 | 4.17 Billion EUR | 21.03% |
| 2021 | 3.44 Billion EUR | 47.68% |
| 2020 | 2.33 Billion EUR | 27.84% |
| 2019 | 1.82 Billion EUR | 16.66% |
| 2018 | 1.56 Billion EUR | 11.5% |
| 2017 | 1.4 Billion EUR | 8.02% |
| 2016 | 1.3 Billion EUR | 16.64% |
| 2015 | 1.11 Billion EUR | 25.09% |
| 2014 | 891.16 Million EUR | 12.58% |
| 2013 | 791.55 Million EUR | -6.4% |
| 2012 | 845.71 Million EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 819.6 Million EUR | -3.55% |
| 2024 Q2 | 860.7 Million EUR | 5.01% |
| 2024 Q3 | 793.6 Million EUR | -7.8% |
| 2023 FY | 3.39 Billion EUR | -18.66% |
| 2023 Q4 | 849.8 Million EUR | 4.82% |
| 2023 Q2 | 832 Million EUR | -7.88% |
| 2023 Q1 | 903.2 Million EUR | -14.94% |
| 2023 Q3 | 810.7 Million EUR | -2.56% |
| 2022 Q2 | 1.03 Billion EUR | 1.05% |
| 2022 Q1 | 1.02 Billion EUR | 11.11% |
| 2022 FY | 4.17 Billion EUR | 21.03% |
| 2022 Q3 | 1.05 Billion EUR | 1.64% |
| 2022 Q4 | 1.06 Billion EUR | 0.87% |
| 2021 Q2 | 838.1 Million EUR | 5.94% |
| 2021 Q4 | 922.32 Million EUR | 2.74% |
| 2021 FY | 3.44 Billion EUR | 47.68% |
| 2021 Q1 | 791.1 Million EUR | 20.66% |
| 2021 Q3 | 897.7 Million EUR | 7.11% |
| 2020 Q1 | 509.9 Million EUR | 8.22% |
| 2020 Q2 | 546.9 Million EUR | 7.26% |
| 2020 Q3 | 623.2 Million EUR | 13.95% |
| 2020 Q4 | 655.65 Million EUR | 5.21% |
| 2020 FY | 2.33 Billion EUR | 27.84% |
| 2019 Q3 | 461.2 Million EUR | 0.48% |
| 2019 Q1 | 435.7 Million EUR | 5.67% |
| 2019 FY | 1.82 Billion EUR | 16.66% |
| 2019 Q4 | 471.16 Million EUR | 2.16% |
| 2019 Q2 | 459 Million EUR | 5.35% |
| 2018 Q2 | 393.5 Million EUR | 7.84% |
| 2018 FY | 1.56 Billion EUR | 11.5% |
| 2018 Q4 | 412.33 Million EUR | 4.31% |
| 2018 Q1 | 364.9 Million EUR | 0.2% |
| 2018 Q3 | 395.3 Million EUR | 0.46% |
| 2017 FY | 1.4 Billion EUR | 8.02% |
| 2017 Q1 | 343.1 Million EUR | 2.36% |
| 2017 Q2 | 359.4 Million EUR | 4.75% |
| 2017 Q3 | 337.9 Million EUR | -5.98% |
| 2017 Q4 | 364.16 Million EUR | 7.77% |
| 2016 Q2 | 323.5 Million EUR | 7.15% |
| 2016 FY | 1.3 Billion EUR | 16.64% |
| 2016 Q4 | 335.19 Million EUR | -1.33% |
| 2016 Q3 | 339.7 Million EUR | 5.01% |
| 2016 Q1 | 301.9 Million EUR | 6.13% |
| 2015 Q3 | 294.9 Million EUR | 6.35% |
| 2015 FY | 1.11 Billion EUR | 25.09% |
| 2015 Q2 | 277.3 Million EUR | 7.44% |
| 2015 Q1 | 258.1 Million EUR | 5.06% |
| 2015 Q4 | 284.45 Million EUR | -3.54% |
| 2014 Q2 | 219.9 Million EUR | 8.27% |
| 2014 Q1 | 203.1 Million EUR | 51.27% |
| 2014 Q3 | 222.5 Million EUR | 1.18% |
| 2014 Q4 | 245.66 Million EUR | 10.41% |
| 2014 FY | 891.16 Million EUR | 12.58% |
| 2013 Q2 | 226.9 Million EUR | 5.88% |
| 2013 Q1 | 214.3 Million EUR | 3.87% |
| 2013 Q3 | 216 Million EUR | -4.8% |
| 2013 Q4 | 134.25 Million EUR | -37.84% |
| 2013 FY | 791.55 Million EUR | -6.4% |
| 2012 FY | 845.71 Million EUR | 0.0% |
| 2012 Q4 | 206.31 Million EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Cegedim SA | 615.99 Million EUR | -451.254% |
| Guerbet SA | 795.65 Million EUR | -326.781% |
| Nexus AG | 241.45 Million EUR | -1306.326% |
| Bastide Le Confort Médical SA | 529.75 Million EUR | -540.994% |
| Revenio Group Oyj | 96.57 Million EUR | -3416.091% |
| Drägerwerk AG & Co. KGaA | 3.37 Billion EUR | -0.658% |
| LNA Santé SA | 736.08 Million EUR | -361.319% |
| Siemens Healthineers AG | 22.36 Billion EUR | 84.816% |
| Medios AG | 1.78 Billion EUR | -90.267% |
| Equasens Société anonyme | 219.78 Million EUR | -1444.989% |
| Stratec SE | 261.91 Million EUR | -1196.509% |